← ANAPTYSBIO, INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $16.7m |
$10.0m
-40.06%
|
$5.0m
-50.00%
|
$8.0m
+60.00%
|
$75.0m
+837.50%
|
$63.2m
-15.77%
|
$10.3m
-83.72%
|
$17.2m
+66.78%
|
$91.3m
+432.03%
|
$234.6m
+157.01%
|
$232.4m
-0.94%
|
|
| Research and Development Expense | $15.4m | $29.4m | $56.2m | $99.3m | $80.0m | $98.5m | $88.8m | — | — | — | $128.8m | |
| General and Administrative Expense | $4.3m | $9.3m | $15.5m | $16.1m | $18.9m | $21.5m | $36.6m | $41.9m | $42.4m | $50.7m | $62.8m | |
| Operating Expenses | $19.7m | $38.8m | $71.7m | $115.4m | $98.9m | $120.0m | $125.4m | $181.6m | $206.2m | $186.7m | $191.6m | |
| Operating Income (Loss) | ($3.0m) |
($28.8m)
-851.44%
|
($66.7m)
-131.83%
|
($107.4m)
-61.01%
|
($23.9m)
+77.77%
|
($56.8m)
-137.92%
|
($115.2m)
-102.69%
|
($164.4m)
-42.77%
|
($114.9m)
+30.08%
|
$47.9m
+141.67%
|
$40.8m
-14.82%
|
|
| Interest Expense | $458k | $1.8m | $1.7m | $1.0m | $0 | $0 | — | — | — | — | $82.7m | |
| Interest Income, Other | — | — | $6.7m | $11.0m | $4.0m | $431k | $7.5m | $18.9m | $19.8m | $13.5m | $11.7m | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($100k) | $200k | — | — | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | ($147k) | $229k | ($159k) | $1k | ($11k) | $37k | $12k | ($2k) | $14k | $5.4m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($632k) | ($27.5m) | ($61.2m) | ($97.2m) | ($19.8m) | ($57.7m) | ($128.7m) | ($163.6m) | ($145.4m) | ($13.1m) | ($26.6m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($4.3m) | ($30.1m) | ($61.8m) | ($97.5m) | ($19.9m) | ($57.8m) | ($128.7m) | ($163.6m) | ($145.2m) | ($13.1m) | ($26.6m) | |
| Income Tax Expense (Benefit) | $0 | $0 | ($192k) | ($152k) | $0 | $0 | $24k | ($4k) | $3k | $164k | $160k | |
| Net Income (Loss) Attributable to Parent | ($4.3m) |
($30.1m)
-606.03%
|
($61.7m)
-105.04%
|
($97.3m)
-57.87%
|
($19.9m)
+79.52%
|
($57.8m)
-189.98%
|
($128.7m)
-122.72%
|
($163.6m)
-27.11%
|
($145.2m)
+11.24%
|
($13.2m)
+90.89%
|
($26.8m)
-102.44%
|
|
| Earnings Per Share, Basic | ($1.62) | ($1.52) | ($2.50) | ($3.60) | ($0.73) | ($2.11) | ($4.57) | ($6.08) | ($5.12) | ($0.46) | ($1.02) | |
| Earnings Per Share, Diluted | ($1.62) | ($1.52) | ($2.50) | ($3.60) | ($0.73) | ($2.11) | ($4.57) | ($6.08) | ($5.12) | ($0.46) | ($1.02) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 27.4m | 28.2m | 26.9m | 28.4m | 28.8m | 28.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 27.4m | 28.2m | 26.9m | 28.4m | 28.8m | 28.3m |